Briganti Alberto, Chun Felix K-H, Salonia Andrea, Gallina Andrea, Farina Elena, Da Pozzo Luigi F, Rigatti Patrizio, Montorsi Francesco, Karakiewicz Pierre I
Department of Urology, Vita-Salute University, Milan, Italy.
BJU Int. 2006 Oct;98(4):788-93. doi: 10.1111/j.1464-410X.2006.06318.x. Epub 2006 Jun 26.
To develop a multivariate nomogram to predict the rate of lymph node invasion (LNI) in patients with clinically localized prostate cancer according to the extent of extended pelvic lymphadenectomy (PLND), which is associated with significantly higher rate of LNI.
The study comprised 781 consecutive patients (median age 66.6 years, range 45-85) treated with PLND and radical retropubic prostatectomy (RRP) for clinically localized prostate cancer. Their median (range) prostate-specific antigen (PSA) level was 7 (1.03-49.91) ng/mL, and their clinical stages were T1c in 433 (55.4%), T2 in 328 (42%) and T3 in 20 (2.6%). Biopsy Gleason sums were <or= 6 in 514 (65.8%), 7 in 204 (26.1%) and 8-10 in 63 (8.1%). Multivariate logistic regression models were used to test the association between predictors including PSA level, biopsy Gleason sum, clinical stage, number of nodes removed and the rate of LNI. Finally, regression coefficients were used to develop a nomogram, which was internally validated with 200 bootstrap re-samples.
The median (range) number of lymph nodes removed was 14 (2-40); LNI was detected in 71 patients (9.1%). The univariate predictive accuracy for total PSA level, clinical stage, biopsy Gleason sum and number of total nodes removed and examined was 64.2%, 59.8%, 74% and 62.9%, respectively. Except for PSA (P = 0.2), all variables were statistically significant multivariate predictors of LNI at RRP (P <or= 0.001). A nomogram based on clinical stage, PSA level, biopsy Gleason sum and the number of total lymph nodes removed was 78.6% accurate, and 1.8% more accurate than a nomogram without the number of removed lymph nodes.
The extent of PLND is directly related to the probability of LNI. The risk of LNI increases linearly, and is proportional to the number of nodes removed and examined. The effect of the increased probability of LNI is weighted more heavily in men with more advanced clinical stage and grade.
根据扩大盆腔淋巴结清扫术(PLND)的范围,建立一个多变量列线图,以预测临床局限性前列腺癌患者的淋巴结侵犯(LNI)率,PLND与LNI率显著升高相关。
本研究纳入了781例连续接受PLND和耻骨后根治性前列腺切除术(RRP)治疗的临床局限性前列腺癌患者(中位年龄66.6岁,范围45 - 85岁)。他们的前列腺特异性抗原(PSA)水平中位数(范围)为7(1.03 - 49.91)ng/mL,临床分期为T1c期433例(55.4%),T2期328例(42%),T3期20例(2.6%)。活检Gleason评分≤6分514例(65.8%),7分204例(2б.1%),8 - 10分63例(8.1%)。采用多变量逻辑回归模型检验包括PSA水平、活检Gleason评分、临床分期、切除淋巴结数量等预测因素与LNI率之间的关联。最后,利用回归系数建立列线图,并通过200次自抽样重采样进行内部验证。
切除淋巴结数量的中位数(范围)为14(2 - 40)个;71例患者(9.1%)检测到LNI。总PSA水平、临床分期、活检Gleason评分以及切除并检查的淋巴结总数的单变量预测准确率分别为64.2%、59.8%、74%和62.9%。除PSA外(P = 0.2),所有变量均为RRP时LNI的统计学显著多变量预测因素(P≤0.001)。基于临床分期、PSA水平、活检Gleason评分和切除的淋巴结总数的列线图准确率为78.6%,比不包含切除淋巴结数量的列线图准确率高1.8%。
PLND的范围与LNI的可能性直接相关。LNI的风险呈线性增加,且与切除和检查的淋巴结数量成正比。在临床分期和分级较高的男性中,LNI可能性增加的影响权重更大。